French drug trial leaves one brain dead and five critically ill

French health minister travels to clinic in Rennes, where all trials of the drug have been suspended

One person is brain dead and five others are seriously ill after taking part in a drug trial for an unnamed pharmaceutical firm at a clinic in north-west France.
The French health ministry said the six patients had been in good health until taking the oral medication. It did not say what the new medicine was intended to be used for, but a source close to the case told AFP that the drug was a painkiller containing cannabinoids, an active ingredient found in cannabis plants.
The health minister, Marisol Touraine, said on Friday the six had been taking part in a “trial of an oral medication being developed by a European laboratory” in Rennes, Brittany. The patients were admitted to hospital at the beginning of this week.
The ministry said the test was carried out by a private establishment “specialised in carrying out clinical trials”. Local media reported that the trial took place at the Biotrial clinic.
The trial was intended to test for side-effects of the new drug. All trials on the drug at the clinic have been suspended and the French state prosecutor has opened an inquiry.
The study was a phase one clinical trial, in which healthy volunteers take the medication to “evaluate the safety of its use, tolerance and pharmacological profile of the molecule”, Touraine said. She is travelling to Rennes where she will give a press conference on Friday afternoon.
Medical trials typically have three phases to assess a new drug or device for safety and effectiveness. Phase one entails a small group of volunteers, and focuses only on safety. Phase two and three are progressively larger trials to assess the drug’s effectiveness, although safety remains paramount.
Every year thousands of volunteers, often students looking to make extra money, take part in such trials. Mishaps are relatively rare, but in 2006 six men fell ill in London after taking part in a clinical trial into a drug developed to fight auto-immune disease and leukaemia.

http://www.theguardian.com/world/2016/jan/15/french-drug-trial-one-person-in-coma-and-five-critically-ill

I bet it wasn't the cannabinoids that harmed them but what it was mixed with.

That's what I thought.

eddie wrote:I bet it wasn't the cannabinoids that harmed them but what it was mixed with.

Actually it could very well be that Eddie:

http://emedicine.medscape.com/article/833828-overview

These things happen sometimes, and it's risk people take if they agree to test the drugs. The are tested thoroughly before they're given to humans, but it's not always predictable as to what will happen in a human.

Very true, and people go on drug trials for many reasons.  Some do it because they are paid, others because they have a sickness that they think the drug might help.  It's horrible when it goes wrong though.

sassy wrote:Very true, and people go on drug trials for many reasons.  Some do it because they are paid, others because they have a sickness that they think the drug might help.  It's horrible when it goes wrong though.

I think that in a Phase I trial, they're healthy volunteers. I think this was a Phase I trial.

So it was, so basically they were just trying to help.  Very sad.

sassy wrote:So it was, so basically they were just trying to help.  Very sad.

They probably got paid as well.

Pay won't do the one who is brain dead much good.

sassy wrote:Pay won't do the one who is brain dead much good.

My point is that they probably weren't just doing it for the good of mankind.

Probably not, but it was for the good of mankind, paid or not.

Well I'll be watching out for news on this one - I have an interest in that kind of thing.